share_log

先聲藥業:自願公告 - 注射用SIM0500(人源化GPRC5D-BCMA-CD3三特異性抗體)獲國家藥品監督管理局簽發藥物臨床試驗批准通知書

SIMCERE PHARMA: VOLUNTARY ANNOUNCEMENT - THE CLINICAL TRIAL APPROVAL FOR SIM0500 FOR INJECTION (A HUMANIZED GPRC5D-BCMA-CD3 TRISPECIFIC ANTIBODY) ISSUED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION

香港交易所 ·  Mar 12 07:44
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more